ATE274918T1 - Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen - Google Patents

Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen

Info

Publication number
ATE274918T1
ATE274918T1 AT97917418T AT97917418T ATE274918T1 AT E274918 T1 ATE274918 T1 AT E274918T1 AT 97917418 T AT97917418 T AT 97917418T AT 97917418 T AT97917418 T AT 97917418T AT E274918 T1 ATE274918 T1 AT E274918T1
Authority
AT
Austria
Prior art keywords
albumin
treatment
conjunctival
active ingredient
present
Prior art date
Application number
AT97917418T
Other languages
English (en)
Inventor
Kazuo Tsubota
Original Assignee
R Tech Ueno Ltd
Kazuo Tsubota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd, Kazuo Tsubota filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE274918T1 publication Critical patent/ATE274918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97917418T 1996-04-19 1997-04-17 Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen ATE274918T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP9809096 1996-04-19
JP10686696 1996-04-26
US75294196A 1996-11-21 1996-11-21
US75292896A 1996-11-21 1996-11-21
PCT/JP1997/001329 WO1997039769A1 (en) 1996-04-19 1997-04-17 Drug composition comprising albumin as active ingredient

Publications (1)

Publication Number Publication Date
ATE274918T1 true ATE274918T1 (de) 2004-09-15

Family

ID=27468604

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97917418T ATE274918T1 (de) 1996-04-19 1997-04-17 Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen

Country Status (11)

Country Link
US (2) US6043213A (de)
EP (1) EP0834320B1 (de)
JP (1) JP3058920B2 (de)
KR (1) KR100455475B1 (de)
CN (1) CN1124158C (de)
AT (1) ATE274918T1 (de)
CA (1) CA2225398C (de)
DE (1) DE69730476T2 (de)
ES (1) ES2227684T3 (de)
NO (1) NO320601B1 (de)
WO (1) WO1997039769A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373166C (en) * 1999-07-28 2009-05-19 Morinaga Milk Industry Co., Ltd. Antiulcer agent
GB0019378D0 (en) * 2000-08-07 2000-09-27 Saugstad Ola D Method
EP1254665B1 (de) * 2001-04-26 2008-01-30 R-Tech Ueno, Ltd. Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose
US20030211043A1 (en) * 2001-09-28 2003-11-13 Korb Donald R. Eye treatment
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US7189697B2 (en) * 2004-04-13 2007-03-13 Trustees Of Tufts College Compositions and uses of a galectin for treatment of dry eye syndrome
US20060232060A1 (en) * 2005-04-13 2006-10-19 Assignee1 Pressure sensitive packing laminate overlay form combination and method of using same
WO2007033020A2 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation for treatment of dry eye
WO2008133928A2 (en) * 2007-04-27 2008-11-06 The Gi Company, Inc. Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
CA2724052A1 (en) * 2008-05-15 2009-11-19 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
KR101422571B1 (ko) 2009-10-13 2014-07-24 삼성전자 주식회사 받침대 및 이를 구비한 세탁기
CN102695954A (zh) * 2009-11-27 2012-09-26 株式会社·R-技术上野 用于治疗干眼和/或角膜和结膜损伤的药剂的筛选方法以及该方法制得的药物组合物
AU2013203609B2 (en) * 2009-11-27 2014-08-21 R-Tech Ueno, Ltd. Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
JP2014501748A (ja) * 2010-12-21 2014-01-23 リコファーマ アーベー 涙代用物
ES2960598T3 (es) 2014-05-08 2024-03-05 Kiora Pharmaceuticals Gmbh Compuestos para el tratamiento de enfermedades y trastornos oftálmicos
DE102015205293A1 (de) 2015-03-24 2016-09-29 Marc Schrott Verfahren zur Herstellung von Augentropfen
EP3437628A4 (de) * 2016-04-01 2019-11-27 Biocoz Global Korea Corp. Kosmetische zusammensetzung mit albumin, hyaluronsäure oder kollagen als wirkstoff in zellkulturmedium
MX2020009235A (es) 2018-03-09 2023-01-16 Kiora Pharmaceuticals Gmbh Formulacion oftalmica.
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
WO2020021477A2 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
MX2023007767A (es) 2020-12-28 2023-07-07 Davol Inc Materiales hemostaticos secos en polvo reactivos que comprenden una proteina y un agente de entrelazado a base de polietilenglicol modificado multifuncional.
WO2024018452A1 (en) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Albumin protein variants, production thereof and uses of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57126422A (en) * 1981-01-29 1982-08-06 Green Cross Corp:The Stabilizing method of lysozyme pharmaceutical
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
IL93996A0 (en) * 1989-04-04 1991-01-31 Alcon Lab Inc Pharmaceutical composition containing a liposome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
JPH05310592A (ja) * 1992-05-11 1993-11-22 Nichirei Corp 創傷治療剤及び医薬製剤
JPH06271478A (ja) * 1993-03-23 1994-09-27 Otsuka Pharmaceut Co Ltd ドライアイ治療剤
EP0637450A3 (de) * 1993-08-04 1995-04-05 Collagen Corp Verfahren und Zusammensetzung zur Wiederbelebung von Nerbgewebe.
US6013628A (en) * 1994-02-28 2000-01-11 Regents Of The University Of Minnesota Method for treating conditions of the eye using polypeptides

Also Published As

Publication number Publication date
ES2227684T3 (es) 2005-04-01
EP0834320A4 (de) 2000-11-22
WO1997039769A1 (en) 1997-10-30
NO320601B1 (no) 2005-12-27
CA2225398A1 (en) 1997-10-30
CA2225398C (en) 2008-07-15
EP0834320B1 (de) 2004-09-01
KR100455475B1 (ko) 2004-12-17
US6043213A (en) 2000-03-28
CN1124158C (zh) 2003-10-15
DE69730476T2 (de) 2005-11-17
JP3058920B2 (ja) 2000-07-04
DE69730476D1 (de) 2004-10-07
KR19990028235A (ko) 1999-04-15
CN1195296A (zh) 1998-10-07
EP0834320A1 (de) 1998-04-08
NO975962D0 (no) 1997-12-18
US6159930A (en) 2000-12-12
NO975962L (no) 1998-02-18

Similar Documents

Publication Publication Date Title
ATE274918T1 (de) Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen
ATE303757T1 (de) Behandlung von augenerkrankungen
ATE480240T1 (de) Zusammensetzung enthaltend latanoprost und behandlungsmethode von erhöhtem augeninnendruck und glaukom
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
DE69930271D1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE60231131D1 (de) Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose
US20110097383A1 (en) Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
AU4672300A (en) Biochemical methods that eliminate corneal scars, opacification and haze
ATE145823T1 (de) Arzneimittel zur topischen anwendung am auge zur behandlung des erhöhten intraokularen drucks
ATE216889T1 (de) Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension
ATE281157T1 (de) Zusammensetzung enthaltend di- und trinatriumsalze von echinochrome zur behandlung von augenerkrankungen
ATE112960T1 (de) Anthocyanidine zur behandlung von augenkrankheiten.
EP1297849A4 (de) Heilmittel für zur behandlung von erkrankungen des sehnervs und so weiter
ES2073245T3 (es) Agentes para el tratamiento de la cornea.
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
Meyers Endophthalmitis.
RU96113475A (ru) Способ хирургического лечения глаукомы
RU94000179A (ru) Глазной гель
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases
RU93025693A (ru) Способ хирургического лечения близорукости
RU94038765A (ru) Способ лечения десцеметоцеле
ATE143594T1 (de) Schnelle miosis mit kontrolle des augeninnendruckes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties